Publications by authors named "Jeff Packman"

Claim this Profile
P
Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.
Robert J Pignolo, Geneviève Baujat, Edward C Hsiao, Richard Keen, Amy Wilson, Jeff Packman

J Bone Miner Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical measures in transthyretin familial amyloid polyneuropathy.
Teresa Coelho, Aaron Vinik, Etta J Vinik, Tara Tripp, Jeff Packman

Muscle Nerve· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
Mathew S Maurer, Donna R Grogan, Daniel P Judge, Rajiv Mundayat, Jeff Packman

Circ Heart Fail· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy.
Etta J Vinik, Aaron I Vinik, James F Paulson, Ingemar S J Merkies, Jeff Packman

J Peripher Nerv Syst· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis.
Giampaolo Merlini, Violaine Planté-Bordeneuve, Daniel P Judge, Hartmut Schmidt, Laura Obici, Jeff Packman

J Cardiovasc Transl Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.
Teresa Coelho, Luis F Maia, Ana Martins da Silva, Márcia W Cruz, Violaine Planté-Bordeneuve, Jeff Packman

J Neurol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.
Teresa Coelho, Luis F Maia, Ana Martins da Silva, Marcia Waddington Cruz, Violaine Planté-Bordeneuve, Jeff Packman

Neurology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Christine E Bulawa, Stephen Connelly, Michael Devit, Lan Wang, Charlotte Weigel, Jeff Packman

Proc Natl Acad Sci U S A· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Taslima Bhuiyan, Stephen Helmke, Ayan R Patel, Frederick L Ruberg, Jeff Packman

Circ Heart Fail· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis